Charles D Ericsson

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Vibrio parahemolyticus septicaemia in a liver transplant patient: a case report
    Rajeev R Fernando
    Department of Internal Medicine, The University of Texas Health Science Center, 6431 Fannin Street, Houston, Texas 77030, USA
    J Med Case Reports 5:171. 2011
  2. ncbi Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea
    Charles D Ericsson
    University of Texas Medical School, Houston, TX 77030, USA
    Clin Infect Dis 41:S557-63. 2005
  3. ncbi Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea
    Charles D Ericsson
    Department of Medicine, University of Texas Houston Medical School, Houston, Texas 77030, USA
    Drug Saf 29:201-7. 2006
  4. ncbi Rifaximin in the treatment of infectious diarrhea
    Charles D Ericsson
    Department of Internal Medicine and Division of Infectious Diseases, University of Texas Houston Medical School, Houston, TX 77030, USA
    Chemotherapy 51:73-80. 2005
  5. ncbi Travellers with pre-existing medical conditions
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Houston Medical School, 1 729 John Freeman Building, 6431 Fannin Street, Houston, TX, USA
    Int J Antimicrob Agents 21:181-8. 2003
  6. ncbi Travellers' diarrhoea
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Houston Medical School, 1 729 John Freeman Building, 6431 Fannin Street, Houston, TX, USA
    Int J Antimicrob Agents 21:116-24. 2003
  7. ncbi Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, and St Luke s Episcopal Hospital, Houston, TX 77030, USA
    J Travel Med 14:312-9. 2007
  8. ncbi Travelers' preferences for the treatment and prevention of acute diarrhea
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030, USA
    J Travel Med 16:172-8. 2009
  9. ncbi Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone
    Herbert L DuPont
    Center for Infectious Diseases, University of Texas School of Public Health, Houston, Texas, USA
    Clin Gastroenterol Hepatol 5:451-6. 2007
  10. ncbi A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
    Herbert L DuPont
    University of Texas Houston, Baylor College of Medicine, St Luke s Episcopal Hospital, and M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Intern Med 142:805-12. 2005

Detail Information

Publications28

  1. ncbi Vibrio parahemolyticus septicaemia in a liver transplant patient: a case report
    Rajeev R Fernando
    Department of Internal Medicine, The University of Texas Health Science Center, 6431 Fannin Street, Houston, Texas 77030, USA
    J Med Case Reports 5:171. 2011
    ..abstract:..
  2. ncbi Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea
    Charles D Ericsson
    University of Texas Medical School, Houston, TX 77030, USA
    Clin Infect Dis 41:S557-63. 2005
    ....
  3. ncbi Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea
    Charles D Ericsson
    Department of Medicine, University of Texas Houston Medical School, Houston, Texas 77030, USA
    Drug Saf 29:201-7. 2006
    ....
  4. ncbi Rifaximin in the treatment of infectious diarrhea
    Charles D Ericsson
    Department of Internal Medicine and Division of Infectious Diseases, University of Texas Houston Medical School, Houston, TX 77030, USA
    Chemotherapy 51:73-80. 2005
    ..Uses limited to enteric indications and its inherently low propensity to induce sustainable resistance among Gram-negative flora favor the sustained usefulness of rifaximin in the treatment of enteric infectious syndromes...
  5. ncbi Travellers with pre-existing medical conditions
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Houston Medical School, 1 729 John Freeman Building, 6431 Fannin Street, Houston, TX, USA
    Int J Antimicrob Agents 21:181-8. 2003
    ..Finally, education of such travellers is paramount; they must understand that risk avoidance is critical and preventative modalities such as vaccination and chemoprophylaxis are never 100% efficacious...
  6. ncbi Travellers' diarrhoea
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Houston Medical School, 1 729 John Freeman Building, 6431 Fannin Street, Houston, TX, USA
    Int J Antimicrob Agents 21:116-24. 2003
    ..The combination of an antibiotic and loperamide is superior to treatment with either agent alone in a several studies and is arguably the treatment of choice for distressing travellers' diarrhoea...
  7. ncbi Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, and St Luke s Episcopal Hospital, Houston, TX 77030, USA
    J Travel Med 14:312-9. 2007
    ....
  8. ncbi Travelers' preferences for the treatment and prevention of acute diarrhea
    Charles D Ericsson
    Department of Medicine, Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030, USA
    J Travel Med 16:172-8. 2009
    ..A survey was designed to assess travelers' willingness to take antibiotic chemoprophylaxis against travelers' diarrhea (TD) or to intervene with antibiotic or symptomatic treatments...
  9. ncbi Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone
    Herbert L DuPont
    Center for Infectious Diseases, University of Texas School of Public Health, Houston, Texas, USA
    Clin Gastroenterol Hepatol 5:451-6. 2007
    ..This study evaluated the efficacy and safety of rifaximin-loperamide in the treatment of travelers' diarrhea...
  10. ncbi A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
    Herbert L DuPont
    University of Texas Houston, Baylor College of Medicine, St Luke s Episcopal Hospital, and M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Intern Med 142:805-12. 2005
    ..Travelers' diarrhea causes substantial morbidity and postinfectious irritable bowel syndrome...
  11. ncbi Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin
    Herbert L DuPont
    Houston School of Public Health, Houston, TX, USA
    Clin Infect Dis 41:S571-6. 2005
    ....
  12. ncbi Rifaximin treatment of pathogen-negative travelers' diarrhea
    Herbert L DuPont
    Center for Infectious Diseases, Houston School of Public Health, The University of Texas, Houston, TX, USA
    J Travel Med 14:16-9. 2007
    ..Antibacterial drugs appear to be effective in shortening the illness of a majority of cases of travelers' diarrhea...
  13. ncbi Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico
    Javier A Adachi
    Center for Infectious Diseases, University of Texas-Houston School of Public Health and Medical School, Houston, Texas, USA
    Clin Infect Dis 37:1165-71. 2003
    ..Azithromycin was found to be a safe and effective alternative to levofloxacin for the treatment of acute travelers' diarrhea in US adult travelers to Mexico...
  14. ncbi Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study
    Ismail M Meraz
    School of Public Health, University of Texas, Houston, TX 77030, USA
    J Travel Med 15:412-8. 2008
    ..Enteropathogens cannot be identified in 40% to 50% of subjects with travelers' diarrhea (TD)...
  15. ncbi Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico
    Hoonmo L Koo
    Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    J Clin Microbiol 48:1673-6. 2010
    ..Significant variation in the prevalence of NoV diarrhea and in the predominant genogroup infecting travelers was demonstrated, dependent upon the specific geographic location and over time...
  16. ncbi Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico
    Alain R Bouckenooghe
    Veterans Affairs Medical Center, Baylor College of Medicine, and University of Texas Medical School and School of Public Health, Houston, Texas, USA
    J Travel Med 9:137-40. 2002
    ..0004), as was the average number of unformed stools passed over 4 days (Mexicans 8.8 versus travelers 17.9 stools; p =.0009..
  17. ncbi Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy
    Rosa M Infante
    Center for Infectious Diseases, The University of Texas-Houston School of Public Health and Medical School, Houston, Texas, USA
    Clin Gastroenterol Hepatol 2:135-8. 2004
    ..The study provides information on the value of the poorly absorbed drug rifaximin in therapy of travelers' diarrhea...
  18. ncbi Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas
    Javier A Adachi
    University of Texas, St. Luke's Episcopal Hospital, and Baylor College of Medicine, Houston, Texas 77030, USA
    Ann Intern Med 136:884-7. 2002
    ..coli and 14 of 32 contained enteroaggregative E. coli. CONCLUSIONS: Contamination with E. coli was common in samples of Mexican tabletop sauces from Guadalajara restaurants. These sauces commonly contained enteric pathogens...
  19. ncbi Expert review of the evidence base for prevention of travelers' diarrhea
    Herbert L DuPont
    Center for Infectious Disease, University of Texas School of Public Health at Houston, Houston, TX 77030, USA
    J Travel Med 16:149-60. 2009
    ..In the following document, the authors used an evidence base when available to determine strength and quality of evidence and when data were lacking, the panel experts provided consensus opinion...
  20. ncbi The role of diet in the treatment of travelers' diarrhea: a pilot study
    David B Huang
    Center for Infectious Diseases, School of Public Health, University of Texas at Houston, Houston, TX 77030, USA
    Clin Infect Dis 39:468-71. 2004
    ..However, a much higher number of subjects would need to be studied to prove this point statistically...
  21. ncbi United States male students who heavily consume alcohol in Mexico are at greater risk of travelers' diarrhea than their female counterparts
    David B Huang
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    J Travel Med 11:143-5. 2004
    ..Nondrinkers also deserve further study in larger numbers to confirm an apparently high attack rate of diarrhea and to explore what risk factors might be involved...
  22. ncbi Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico
    Javier A Adachi
    Center for Infectious Diseases, Medical School and School of Public Health, University of Texas-Houston, Houston, TX, USA
    J Infect Dis 185:1681-3. 2002
    ..Symptomatic EAEC infection occurred early after arrival in Guadalajara, Mexico, and was as common as ETEC infection. Asymptomatic EAEC infection was recurrent...
  23. ncbi Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation
    John F Mohr
    Division of Infectious Diseases and Center for the Study of Emerging and Re emerging Pathogens, University of Texas Health Science Center Houston, TX 77030, USA
    Pharmacotherapy 25:426-8. 2005
    ..Measures to prevent confusion and aid in understanding the differences between lipid and nonlipid formulations of amphotericin B should be implemented...
  24. ncbi Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury
    John F Mohr
    Division of Infectious Diseases, University of Texas Health Science Center at Houston, 6431 Fannin, MSB 2 112, Houston, Texas 77030, USA
    Antimicrob Agents Chemother 52:1891-3. 2008
    ..In burn patients, daptomycin at 10 to 12 mg/kg of body weight/day would be required to achieve drug exposures similar to those for healthy volunteers receiving 6 mg/kg...
  25. ncbi Therapy of travelers' diarrhea with rifaximin on various continents
    Robert Steffen
    Division of Communicable Diseases, Institute of Social and Preventive Medicine of the University, Zurich, Switzerland
    Am J Gastroenterol 98:1073-8. 2003
    ..No relevant side effects were reported. CONCLUSION: Rifaximin is efficacious and safe for treatment of travelers' diarrhea at daily doses of 600 mg or higher...
  26. ncbi A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea
    David N Taylor
    Salix Pharmaceuticals, Inc, Morrisville, North Carolina, USA
    Am J Trop Med Hyg 74:1060-6. 2006
    ..35 versus rifaximin). Rifaximin was less effective than ciprofloxacin for invasive intestinal bacterial pathogens. Oral rifaximin is a safe and effective treatment of travelers' diarrhea caused by noninvasive pathogens...
  27. ncbi The practice of travel medicine: guidelines by the Infectious Diseases Society of America
    David R Hill
    National Travel Health Network and Centre, London School of Hygiene and Tropical Medicine, London, WC1E 6AU, England
    Clin Infect Dis 43:1499-539. 2006
  28. ncbi Transfusion-transmitted malaria: how satisfactory are current preventative measures?
    Firas Alkassab
    Am J Med 119:e1-2. 2006